Shanxi Liye Pharmaceutical Co., Ltd.
-
Founded in:
2017-06-26 -
Country:
China -
Address:
No. 21, Huagong Road, Jinyuan District, Taiyuan City, Shanxi Province -
Tax NO.:
91140100MA0HJG3U47 -
Registered Funds:
45 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ciprofloxacin hydrochloride |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. |
93107-08-5 | 37 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
Antipyretic and analgesic effects
More
Antipyretic and analgesic effects |
250mg | 103-90-2 | 68 |
| Caffeine |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
15mg | 0 | |
| Chlorphenamine maleate |
Anti-allergic effect
More
Anti-allergic effect |
1mg | 113-92-8 | 28 |
| Atificial Cow-bezoar |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
10mg | 1002-00-2 | 2 |
| Sucrose |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
57-50-1 | 73 | |
| Starch |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
9005-25-8 | 79 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chloramphenicol |
This product is a broad-spectrum antibiotic, the mechanism of action is to inhibit bacterial protein synthesis, and is effective against most Gram-negative and some Gram-positive bacteria, as well as Chlamydia trachomatis and Rickettsia.
More
This product is a broad-spectrum antibiotic, the mechanism of action is to inhibit bacterial protein synthesis, and is effective against most Gram-negative and some Gram-positive bacteria, as well as Chlamydia trachomatis and Rickettsia. |
2.5mg | 56-75-7 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naphazoline |
It has the effect of directly stimulating vascular α1 receptors and causing vasoconstriction, thereby alleviating congestion and edema caused by inflammation.
More
It has the effect of directly stimulating vascular α1 receptors and causing vasoconstriction, thereby alleviating congestion and edema caused by inflammation. |
835-31-4 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Naphazoline |
It has the effect of directly stimulating vascular α1 receptors and causing vasoconstriction, thereby alleviating congestion and edema caused by inflammation
More
It has the effect of directly stimulating vascular α1 receptors and causing vasoconstriction, thereby alleviating congestion and edema caused by inflammation |
835-31-4 | 0 |